Health
New partnership aims to advance predictive tests for multiple myeloma in Ireland – News-Medical.Net
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma, the second most common blood cancer in Ireland.
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma (MM), the second most common blood cancer in Ireland.
The study will be carried out at Beaumont Hospital Dublin and run through the Blood Cancer Network Ireland with several other cancer hospitals in Ireland participating. It represents a collaboration between RCSI University of Medicine and Health Sciences and SkylineDx with fun…
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General11 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General21 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General18 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank